Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -8 of 8 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Role of Soy Supplementation in Prostate Cancer Development

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Biomarker/Laboratory analysis, Natural history/Epidemiology, Tissue collection/Repository				Active				18 and over				Other				CLIN-006-05S PJV0110, NCT00255125

Last Modified: 6/11/2008 First Published: 7/14/2006


2.		Phase III Randomized Study of Soy Protein/Isoflavones and Venlafaxine on Vasomotor Symptoms in Patients With Prostate Cancer Undergoing Hormonal Manipulation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Active				21 and over				NCI				CCCWFU-97405 CCCWFU 97405, CCCWFU-BG05-529, NCT00354432

Last Modified: 7/23/2008 First Published: 8/3/2007


3.		Phase III Randomized Study of the Effects of Dietary Soy on Estrogens in Breast Fluid, Serum, and Urine Samples From Healthy Women

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Biomarker/Laboratory analysis, Prevention				Active				30 to 45				NCI				UHM-CHS-4116 CHS 14116, NCT00513916


4.		A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Supportive care				Active				20 to 70				Other				DOH96-TD-I-111-003 NCT00555516


5.		Soy Isoflavones and Breast Cancer Risk Reduction

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Active				30 to 42				NCI, Other				03-260 UTMB GCRC #635, NIH R01-CA95545, NIH NCRR GCRC M01 RR00073, NCT00204490

Last Modified: 5/20/2008 First Published: 7/6/2007


6.		Phase II Study of Cholecalciferol and Soy Supplementation in Patients With Biochemically Recurrent Prostate Cancer Following Failed Definitive Local Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				Over 18				NCI				CCCWFU-85106 CCCWFU-IRB00000371, CCCWFU 85106, NCT00499408


7.		Soy Derivatives for Control of Hot Flashes in Men on Androgen Deprivation Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Active				18 and over				Other				9639 NCT00594620


8.		Soy, Selenium and Breast Cancer Risk

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Biomarker/Laboratory analysis, Prevention				Active				35 to 50				Other				R14697 07/Q0101/10, NCT00555386

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute